TY  - GEN
AU  - Hussein,Ayad Ahmed
AU  - Al-Zaben,Abdulhadi
AU  - Ghatasheh,Lubna
AU  - Natsheh,Abeer
AU  - Hammada,Tuka
AU  - Abdel-Rahman,Fawzi
AU  - Abu-Jazar,Husam
AU  - Sharma,Shanta
AU  - Najjar,Rula
AU  - Frangoul,Haydar
TI  - Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major
SN  - 1545-5017
PY  - 2013///0827
KW  - Adolescent
KW  - Adult
KW  - Antilymphocyte Serum
KW  - administration & dosage
KW  - Busulfan
KW  - Child
KW  - Child, Preschool
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Female
KW  - Follow-Up Studies
KW  - Graft Rejection
KW  - etiology
KW  - Graft Survival
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Immunologic Factors
KW  - Infant
KW  - Male
KW  - Myeloablative Agonists
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Survival Rate
KW  - Tissue Donors
KW  - Transplantation Conditioning
KW  - methods
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - beta-Thalassemia
KW  - mortality
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article
UR  - https://doi.org/10.1002/pbc.24493
ER  -